The dialogue centered on enhancing Uzbekistan’s pharmaceutical regulatory framework by drawing on advanced international practices, building professional connections with European regulatory agencies, and exploring promising areas for collaboration.

The parties explored the use of advanced methods within the current pharmaceutical regulatory framework and addressed the challenges of sharing expertise among regulatory agencies.

Opportunities included creating direct communication channels between experts, hosting training seminars, and launching joint initiatives to improve specialists’ qualifications.